Asadi Milad, Zafari Venus, Sadeghi-Mohammadi Sanam, Shanehbandi Dariush, Mert Ufuk, Soleimani Zahra, Caner Ayşe, Zarredar Habib
Department of Basic Oncology, Ege University, Institute of Health Sciences, Izmir, Turkey.
Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Bioimpacts. 2024 Dec 7;15:30713. doi: 10.34172/bi.30713. eCollection 2025.
INTRODUCTION: The tumor microenvironment (TME) plays a pivotal role in cancer progression, influencing tumor initiation, growth, invasion, metastasis, and response to therapies. This study explores the dynamic interactions within the TME, particularly focusing on self-organization-a process by which tumor cells and their microenvironment reciprocally shape one another, leading to cancer progression and resistance. Understanding these interactions can reveal new prognostic markers and therapeutic targets within the TME, such as extracellular matrix (ECM) components, immune cells, and cytokine signaling pathways. METHODS: A comprehensive search method was employed to investigate the current academic literature on TME, particularly focusing on self-organization in the context of cancer progression and resistance across the PubMed, Google Scholar, and Science Direct databases. RESULTS: Recent studies suggest that therapies that disrupt TME self-organization could improve patient outcomes by defeating drug resistance and increasing the effectiveness of conventional therapy. Additionally, this research highlights the essential of understanding the biophysical properties of the TME, like cytoskeletal alterations, in the development of more effective malignancy therapy. CONCLUSION: This review indicated that targeting the ECM and immune cells within the TME can improve therapy effectiveness. Also, by focusing on TME self-organization, we can recognize new therapeutic plans to defeat drug resistance.
引言:肿瘤微环境(TME)在癌症进展中起着关键作用,影响肿瘤的起始、生长、侵袭、转移以及对治疗的反应。本研究探讨了肿瘤微环境内的动态相互作用,尤其关注自组织——肿瘤细胞与其微环境相互塑造的过程,导致癌症进展和耐药性。了解这些相互作用可以揭示肿瘤微环境中的新预后标志物和治疗靶点,如细胞外基质(ECM)成分、免疫细胞和细胞因子信号通路。 方法:采用全面的检索方法,在PubMed、谷歌学术和科学Direct数据库中,研究关于肿瘤微环境的当前学术文献,尤其关注癌症进展和耐药背景下的自组织。 结果:最近的研究表明,破坏肿瘤微环境自组织的疗法可以通过克服耐药性和提高传统疗法的有效性来改善患者预后。此外,这项研究强调了在开发更有效的恶性肿瘤治疗方法时,了解肿瘤微环境生物物理特性(如细胞骨架改变)的重要性。 结论:本综述表明,靶向肿瘤微环境中的细胞外基质和免疫细胞可以提高治疗效果。此外,通过关注肿瘤微环境自组织,我们可以识别出克服耐药性的新治疗方案。
Front Pharmacol. 2024-11-12
Cancer Commun (Lond). 2023-5
Biomolecules. 2024-4-4
Cell Biochem Biophys. 2024-3
Cancers (Basel). 2023-3-8
Signal Transduct Target Ther. 2023-2-17
J Transl Med. 2022-11-22
Explor Target Antitumor Ther. 2020
Curr Mol Med. 2023-5-30